India’s Lupin settles US patent dispute with Astellas Pharma for $90 million
India’s Lupin settles US patent dispute with Astellas Pharma for $90 million
Related Posts
Popular News
Latest News
How the NFL Charmed Londoners
With the NFL playing more games in places as far afield as Brazil, football has never been more globally popular....
More than 1 million homeowners are underwater on their mortgage — a 7-year high. Here’s what experts advise they do.
About 1.1 million homeowners were underwater on their mortgages at the end of last year as home prices stalled, signaling...
Google Is Rolling Out Two New Ways to Remove Your Sensitive Data From Search
Google announced two new ways for users to remove their sensitive information from the web Tuesday morning—or, at least, remove...
Canton Network powers first private stablecoin payroll, accelerating institutional blockchain adoption
The Canton Network, a public blockchain built for regulated financial markets, today completed the first real-world payroll transaction using private...
Welcome to Global Finances Daily, your go-to source for all things finance. Our mission is to provide our readers with valuable information and insights to help them achieve their financial goals and secure their financial future.